BackgroundCheckpoint Inhibitor with bevacizumab is unaffordable for most in India and other LMICs. Low dose nivolumab (LD Nivo) has shown comparable efficacy in other solid tumors such as...
BackgroundThe combination of atezolizumab and bevacizumab (A+B) is now the standard of care for the first-line systemic treatment of unresectable hepatocellular carcinoma (HCC). This stud...
BackgroundRecent trends have identified an increasing number of young individuals with rectal and colon cancers. These individuals, who are younger than 50 years old, in most instances wo...
BackgroundAfter liver metastasis, lung is the second most common metastatic target organ of colorectal cancer (CRC). This study aimed to explore the clinicopathological features of lung m...
BackgroundThere was a survival paradox in the AJCC TNM staging manual for colorectal cancer (CRC) - some patients at later stages have a better prognosis than those at earlier stages. We ...
BackgroundIndeterminate solitary pulmonary nodules are often encountered on CT scans, and diagnosis of solitary pulmonary metastasis (PM) is important for patients with colorectal cancer ...
BackgroundAppendiceal Carcinoma (AC) and Small Bowel Adenocarcinoma (SBA) are rare malignancies, accounting for approximately 5% of all gastrointestinal cancers. Due to its rarity, high-q...
Background5-fluorouracil (5-FU) and its prodrug capecitabine are Fluoropyrimidines, widely used in colorectal cancer. The prevention of adverse effects related to severe toxicity of Fluor...
BackgroundKIT and / or PDGFRA activation mutation is the initial molecular event of gastrointestinal stromal tumor (GIST), and the molecular mechanism leading to the malignant progression...
BackgroundPancreatic cancer is a disease with high mortality. In most cases, it is diagnosed in advanced stages and median overall survival is less than 12 months. Time to diagnosis and t...